Navigation Links
Sigma-Aldrich® Receives National Institutes of Health Funding for Cardiovascular Disease Research
Date:8/4/2010

ST. LOUIS, Aug. 5 /PRNewswire-FirstCall/ -- Sigma-Aldrich® (Nasdaq: SIAL) today announced it has entered into an agreement with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, and Boston University (BU) to develop methods to measure several potential biomarkers of atherosclerotic cardiovascular disease (CVD) using plasma samples from the NHLBI's Framingham Heart Study (FHS), one of the most prestigious clinical studies in medicine.  Funding for the project is provided by the NHLBI to Sigma-Aldrich under a research subaward agreement with BU.

The FHS began in 1948 as a study of more than 5,000 residents of Framingham, Massachusetts, to identify the factors that increase the risk for CVD.  Since then, it has expanded to include over 14,000 participants from three generations within families.  Using the results of FHS, researchers have identified a host of risk factors, including high blood cholesterol levels, elevated blood pressure, smoking, diabetes and obesity.  The FHS is funded by the NHLBI and conducted in collaboration with BU's School of Medicine and School of Public Health.

Sigma® Life Science, the innovative biological products and services business of Sigma-Aldrich, plans to work with NHLBI and BU to provide for the analysis of plasma samples from 7,000 participants to investigate 180 potential biomarkers for CVD.  Over the course of this five-year project, Sigma Life Science expects to develop antibody reagents for each identified target biomarker and incorporate the reagents into a multiplexed, high-throughput platform to measure the proteins
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis
2. Accurays CyberKnife® G4 System Receives Shonin Approval
3. AdvanDx Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light® PNA FISH®
4. Abbotts SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths
5. Instrumentation Laboratory Receives FDA Clearance for New Automated Total Bilirubin Assay on GEM Premier 4000 Critical Care Analyzer
6. QRxPharma Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo®IR Development and Registration
7. Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
8. CardioGenics Holdings Inc. Receives New Ticker Symbol
9. Actavis Receives Approval of Bupropion HCl SR 100mg and 200mg in the U.S.
10. Trinity Orthopedics Receives Patent Allowance for Sagittally Stable Spinal Fixation System
11. Caraco Pharmaceutical Laboratories, Ltd. Receives Notice Regarding NYSE Amex Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... TORONTO , Sept. 2, ... ) (OTCQB: GNBT) today announced that its ... cannabis co-development arrangement with CannScience Innovations Inc. ... Generex and CannScience have entered into ... Pursuant to the Agreement, Generex has licensed ...
(Date:9/2/2015)... Sept. 2, 2015  MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, today announced results ... Logo - http://photos.prnewswire.com/prnh/20140805/133834 ... am quite pleased with how the Company is positioned ... , Ph.D., President and Chief Executive Officer of MEI ...
(Date:9/2/2015)... Sept. 2, 2015 Relmada Therapeutics, Inc. (OTCQB: ... the treatment of chronic pain, announced today that the ... the FBR Second Annual Healthcare Conference and BioCentury NewsMakers ... FBR Second Annual Healthcare Conference Date:  Wednesday, ... No presentation, investor meetings only ...
Breaking Medicine Technology:Generex Announces Formalization of Buccal Cannabis Co-Development Plan 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 3MEI Pharma Reports Fiscal Year 2015 Results 2MEI Pharma Reports Fiscal Year 2015 Results 3MEI Pharma Reports Fiscal Year 2015 Results 4MEI Pharma Reports Fiscal Year 2015 Results 5MEI Pharma Reports Fiscal Year 2015 Results 6MEI Pharma Reports Fiscal Year 2015 Results 7Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2
... Solutions, Inc. announced today that it has acquired ... acquisition creates an undisputed leadership position in product ... motion preservation. "This is a win for patients ... President & CEO, Geoff Pardo. "This consolidation ...
... Nov. 6 Virtual Health Technologies, Inc. (OTC Bulletin Board: ... to sell all health care related assets to Wound Management ... the Board of Directors and shareholders of VHGI. ... potential stock dividend, royalty stream and cash realized from the ...
Cached Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4
(Date:9/2/2015)... ... ... Good health and a good cause paired up at The Barclays this ... $11,000 to the New Jersey Golf Foundation through its Healthy Steps Challenge. After ... Horizon BCBSNJ challenged PGA TOUR golfer and NJ native Morgan Hoffmann to add more ...
(Date:9/2/2015)... ... 02, 2015 , ... The Hydration Room, Orange County’s first ... second location this week at 31542 S. Coast Hwy, Suite #4, Laguna Beach, ... for patients to relax while receiving safe and effective therapies. Also offering complimentary ...
(Date:9/2/2015)... WI (PRWEB) , ... September 02, 2015 , ... ... Cypress Benefit Administrators is taking action after seeing a significant increase ... TPA’s Argus Claim Review division has found many cases of OON ASCs encouraging ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Amada Senior Care, ... office in Kansas – its Johnson County location. Amada franchise partners Mike ... has a registered nurse background and spent over 20 years in medical device sales ...
(Date:9/2/2015)... Fredericksburg, VA (PRWEB) , ... September 02, 2015 ... ... integrator of document imaging, content, records and case management solutions and services to ... of PurePAGE®, its Image Re-sizing and Image Clean-up utility for IBM’s Datacap document ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3
... Wash. , Feb. 4 The Carol Milgard Breast ... and Drug Administration (FDA) for adhering to the most rigorous quality ... (MQSA).  Receiving the "All Items in Compliance" rating from the FDA ... not received this high quality standard.   , John Peixotto ...
... PALM BEACH, Fla. , Feb. 4 The American ... suffer from some type of cardiovascular disease. Many of those people ... event like the Super Bowl or World Cup where the tension ... rates from heart attacks in 2002 and 2001, doctors in ...
... cancer is the second leading cause of cancer-related deaths in ... of screening for this disease, rates of screening for colorectal ... cancer, particularly breast and cervical. Although the screening rates in ... from 20-30 percent in 1997 to nearly 55 percent in ...
... for athletes to cheat, researchers say , THURSDAY, Feb. 4 ... scientists are warning of a new breed of performance-enhancing agents ... to detect. , , Some researchers are already ... how they can modify genes to boost endurance or muscle ...
... , GAINESVILLE, Fla. , Feb. 4 ... announce today that they have jointly selected Sg2 , a healthcare ... children,s hospital. The assessment began in January with findings projected to be ... at Sg2 will handle this very important assessment, delivering the ...
... , , , ... /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-,Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), ... materials for,use in pharmaceutical, nutraceutical and food production, today announced,preliminary ... Huifeng Bio-Pharmaceutical Technology anticipates revenues between $13,million ...
Cached Medicine News:Health News:Carol Milgard Breast Center Awarded Highest Government Rating for Mammography Sites 2Health News:Top 10 Ways to Avoid a Heart Attack This Super Bowl 2Health News:Top 10 Ways to Avoid a Heart Attack This Super Bowl 3Health News:Panel calls for reducing colorectal cancer deaths by striking down barriers to screening 2Health News:'Gene Doping' May Be Next Wave of Sports Tampering 2Health News:'Gene Doping' May Be Next Wave of Sports Tampering 3Health News:Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Children's Hospital 2Health News:Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Children's Hospital 3Health News:Huifeng Bio-Pharmaceutical Provides Preliminary 2009 Financial Results and 2010 Guidance 2Health News:Huifeng Bio-Pharmaceutical Provides Preliminary 2009 Financial Results and 2010 Guidance 3
The sterile cardiac blanket is utilized during surgical procedures that require access to the upper half of the body. Warms groin area while providing easy access to the area through a perforated ope...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The adult underbody blanket is conveniently positioned on the table before the patient arrives to the procedure suite....
The cardiac access blanket helps maintain normothermia and allows unrestricted access to the patient....
Medicine Products: